Patents
Patents for C07K - Peptides (3,738)
08/2008
08/21/2008US20080199439 Displaces inhibitor of apoptosis proteins (IAP) from caspase; modification of light emission when bound to cell; selectively damages or kills neoplastic cells
08/20/2008EP1958956A2 Peptidomimetic protease inhibitors
08/14/2008US20080193466 Administering human antibody, or an antigen-binding fragment thereof, to subject, wherein antibody dissociates from human TNF alpha with a Kd of 1x10-8 M or less and a Koff rate constant of 1x10-3 s-1 or or less, and neutralizes human TNF alpha cytotoxicity with an IC50 of 1x10-7 M or less in L929 assay
08/13/2008EP1678196B1 Sulfonylamino-peptidomimetics active on the somatostatin receptor subtypes 4 (sstr4) and 1 (sstr1)
08/13/2008CN101240013A High purity lipopeptides, lipopeptide micelles, processes for preparing same
08/12/2008US7410975 Small molecule toll-like receptor (TLR) antagonists
08/12/2008CA2135787C Polypeptide bombesin antagonists
08/07/2008WO2007076322A8 Compositions and methods for attenuating mitochondria-mediated cell injury
08/07/2008US20080187548 Ny-Eso-1 Peptides Which Bind To Class II Molecules And Uses Thereof
08/07/2008US20080187540 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders
08/07/2008US20080187493 Peptide-Based Compounds
07/2008
07/31/2008US20080181908 Genes and proteins, and their use
07/31/2008US20080181906 For inducing neutralizing antibodies against HIV; hairpin motif; HIV gp120; hydrogen bonding
07/29/2008US7405275 Nucleic acid and vectors encodes antibodies ; antigen binding fragments
07/29/2008CA2160121C T cell epitopes of the major allergens from dermatophagoides (house dust mite)
07/24/2008US20080175855 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines
07/23/2008EP1946109A1 Method for detecting autoantibodies formed in rheumatoid arthritis
07/23/2008EP1745070A4 Peptide stabilization
07/23/2008EP1372696B1 Methods for treating rheumatic diseases using a soluble ctla4 molecule
07/17/2008WO2004081029A3 Novel non-invasive marker for liver disease
07/17/2008DE4393381B4 PTH-Verbindungen mit PTH-ähnlicher Aktivität, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und deren Verwendungen PTH compounds having PTH-like activity, to processes for their preparation, pharmaceutical compositions containing them and their uses
07/16/2008EP1944322A2 Treatment of TNF alpha related disorders
07/16/2008EP1944312A1 Peptides that specifically bind HGF receptor (CMET) and uses thereof
07/16/2008EP1575986A4 Peptides and methods for cell death regulation
07/16/2008EP1476541B1 Cytokine (zcytor17 ligand)
07/16/2008EP1311542B1 Tolerogenic peptides
07/15/2008US7399474 Administering to a vertebrate an amount of a polynucleotide operatively encoding at least an immunogenic portion of the csa operon and having at least about 15 nucleotides; for prevention of enterotoxigenic e. coli colonization (diarrhea)
07/15/2008CA2142370C T cell epitopes of ryegrass pollen allergen
07/10/2008US20080166763 Human toll homologues
07/08/2008CA2148907C Treatment of inflammatory bowel disease with ifn-gamma inhibitors
07/03/2008US20080161238 Nucleic acid molecules encoding bacterial autoinducer inactivation proteins as targets for engineering disease resistance
07/03/2008US20080160540 Polypeptides Related to Natriuretic Peptides and Methods of Their Identification and Use
07/03/2008US20080160016 Compositions and methods of tolerizing a primate to an antigen
07/02/2008EP1939297A1 Alzheimer's disease secretase
07/01/2008US7393529 Antiallergens
06/2008
06/25/2008EP1935427A2 Methods for treating rheumatoid diseases using a soluble CTLA4 mutant molecule
06/25/2008CN100397082C HCV-free-blood external preparing method
06/24/2008US7390781 Methods of using truncated glial cell line-derived neurotrophic factor
06/24/2008US7390526 Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon
06/19/2008US20080145373 Hepatitis B surface antigens; keyhole limpet hemocyanin; albumin; heat shock proteins
06/18/2008EP1931706A1 Collagen receptor i-domain binding modulators
06/17/2008US7387998 STQ peptides
06/12/2008US20080139464 Isolated Ny-Eso-1 Peptides Which Bind To Hla Class II Molecules And Uses Thereof
06/12/2008US20080138345 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders
06/05/2008US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors
06/04/2008CN100392079C Protein C or activated protein C-like molecules
05/2008
05/29/2008US20080125355 Endogenous Peptide and Active Subfragments Thereof
05/29/2008US20080124353 Proteinase k resistant surface protein of neisseria meningitidis
05/29/2008US20080124351 Proteinase k resistant surface protein of neisseria meningitidis
05/29/2008US20080124337 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics
05/28/2008CN100390289C Method for producing influenza hemagglutinin multivalent vaccines
05/27/2008US7378252 Signal transduction
05/22/2008US20080119390 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus
05/14/2008EP1664332A4 Kinase and phosphatase assays
05/14/2008CN101177456A Modified transferrin fusion proteins
05/14/2008CN101177455A Modified transferrin fusion proteins
05/14/2008CN100387718C Proteinase K resistant surface protein of neisseria meningitidis
05/13/2008US7371820 Nutraceuticals for the treatment, protection and restoration of connective tissues
05/13/2008US7371812 Antiangiogenic peptides
05/08/2008US20080108566 Analogues of GLP-1
05/08/2008US20080107676 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development
05/08/2008US20080107675 Using neisserial surface protein nucleotide sequences as tool in detection, prevention and treatment of microorganismal infection; immunodiagnostics; immunotherapeutics; vaccine development
05/08/2008US20080107674 Proteinase k resistant surface protein of neisseria meningitidis
05/07/2008EP1918298A2 Peptide
05/07/2008EP1614140A4 Mass spectrometry data analysis techniques
05/06/2008US7368530 Human intestinal Npt2B
05/01/2008US20080103292 Glycopeptide derivatives and pharmaceutical compositions containing the same
04/2008
04/30/2008CN100384880C Modified peptides as therapeutic agents
04/30/2008CN100384879C Modified peptides as therapeutic agents
04/29/2008US7365162 Stabilized bioactive peptides and methods of identification, synthesis, and use
04/29/2008US7365154 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases
04/23/2008CN101166753A Polymer conjugates of mutated neublastin
04/22/2008US7361735 Comprises nucleotide sequences coding lipopolysaccharide induced tumor necrosis factor - alpha factor (LITAF) proteins for use in treatment and prevention of cell proliferative disorders; antitumor agents; immunotherapy
04/16/2008CN101161284A Novel antimicrobial peptides with heparin binding activity
04/15/2008US7358044 Prophylactic and therapeutic benefits of a new class of immune stimulating peptides
04/09/2008EP1680442A4 Pif peptides biologic activities, site of action, and the antibody to detect pif
04/08/2008US7354905 Thrombosis therapy; anticoagulants
04/08/2008US7354769 Comparing the ability of N,N-bis(3-D-gluconamidopropyl)-deoxycholamine to inhibit binding of IGFBP-1 or -3 to IGF-1 with the ability of a candidate indirect agonist of IGF-1 to identify effective agonists
04/03/2008US20080081050 Vaccine against streptococcus pneumoniae
04/02/2008CN101152574A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
04/02/2008CN101152573A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
04/01/2008US7351791 Intermediate for preparing glycopeptide derivatives
04/01/2008US7351790 Peptide-based compounds
03/2008
03/27/2008US20080076713 Peptides selectively lethal to malignant and transformed mammalian cells
03/25/2008US7348403 Contacting a peptide with the agent under conditions permitting formation of a phosphorus-based ester; and determining whether a phosphorus-based ester has formed between the peptide and the agent; inactivation of organophosphorus-based insecticides and chemical warfare agents
03/25/2008US7348002 peptides and monoclonal antibodies used as blocking agents, that disrupt the interaction between collagen and integrins; prophylaxis of inflammatory diseases
03/20/2008WO2004111075A3 Alternative reading frame polypeptides for treatment
03/20/2008US20080070264 Using glial cell line derived neurotrophic factor receptor as tool in identifying modulator for prevention and treatment of cell proliferative disorders
03/20/2008US20080069849 Genetic engineered polypeptide; bactericides, viricides, fungicides, parasiticides
03/13/2008US20080063653 vector-based vaccine may well aid in the development of effective vaccines for a range of human cancers; nucleic acid; agonist polypeptide derived from a mucin tumor antigen; genetic vaccine
03/11/2008US7341838 Polypeptides related to natriuretic peptides and methods of their identification and use
03/06/2008US20080058249 Complexes
03/05/2008EP1613343A4 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
03/04/2008US7338660 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40
02/2008
02/21/2008US20080044433 Epitopes of hepatitis C virus
02/20/2008CN100369953C Water-soluble polymer alkanals
02/19/2008US7332613 use for quantitative protein expression profiling; reagent for mass spectrometric analysis of proteins comprising a tag molecule with a reactive site for stably associating with a protein, an isotope label, and a biotin compound linked to the tag through a pH or reducing agent sensitive bond
02/19/2008US7332485 Peptide deformylase inhibitors
02/19/2008CA2305872C Determination of cellular growth abnormality
02/14/2008US20080039401 For allergy such as asthma; modulating interleukin (IL)-9 expression
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 38